The impact of nonclinical factors on care use for patients with depression: A STAR*D report

CNS Neuroscience and Therapeutics

Volumn 15, Issue 4, 2009, Pages 320-332

  Kashner, T Michael ^a,b   Trivedi, Madhukar H ^a   Wicker, Annie ^c   Fava, Maurizio ^d   Wisniewski, Stephen R ^e   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cost of care; Disease management system; Healthcare utilization; Program evaluation; Severe mental illness

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL RESEARCH; COMPUTER AIDED DESIGN; DISEASE PREDISPOSITION; EDUCATION; FEMALE; HEALTH CARE NEED; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL SERVICE; MENTAL FUNCTION; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; OUTPATIENT; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; RACE DIFFERENCE; REMISSION; SEX DIFFERENCE; SYMPTOM; TELEPHONE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CAUSALITY; CITALOPRAM; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449395239     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2009.00091.x     Document Type: Article

References (69)

1. Stoudemire A, Frank R, Hedemark N. The economic burden of depression. Gen Hosp Psychiatry 1986 8 : 387 394.
2. Rice DP, Miller LS. The economic burden of affective disorders. Adv Health Econ Health Serv Res 1993 14 : 21 37.
3. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer C III. Affective disorders. In : Robins LN, Regier DA, editors. Psychiatric disorders in America: The Epidemiologic Catchment Area Study. New York : The Free Press, 1991 53 80.
4. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994 51 : 8 19.
5. Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998 44 : 348 360.
6. Greenberg PE, Leong SA, Birnbaum HG. Cost of depression: Current assessment and future directions. Expert Rev Pharmacoecon Outcomes Res 2001 1 : 69 76.
7. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993 54 : 405 418.
8. U.S. Bureau of Labor Statistics, Consumer Price Index of urban wage earners and clerical workers for medical care and all items. Series CWUR0000SA0 and CWUR0000SAM. http://www.bls.gov accessed 03/04/2006).
9. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996 274 : 740 743.
10. Gwynn RC, McQuistion HL, McVeigh KH, Garg RK, Frieden TR, Thorpe LE. Prevalence, diagnosis, and treatment of depression and generalized anxiety disorder in a diverse urban community. Psychiatr Serv 2008 59 : 641 647.
11. Pearson SD, Katzelnick DJ, Simon GE, Manning WG, Helstad CP, Henk HJ. Depression among high utilizers of medical care. J Gen Intern Med 1999 14 : 461 468.
12. Jones J, Amaddeo F, Barbui C, Tansella M. Predicting costs of mental health care: A critical literature review. Psychol Med 2007 37 : 467 477.
13. Carr JV, Lewin TJ, Neil AL, Halpin SA, Holmes S. Premorbid, psychosocial and clinical predictors of the costs of schizophrenia and other psychoses. Br J Psychiatry 2004 184 : 517 525.
14. Ginsberg G, Lerner Y, Mark M, Popper M. Prior hospitalization and age as predictors of mental health resource utilization in Israel. Soc Sci Med 1997 44 : 623 633.
15. Knapp M, Beecham J, Anderson J et al. The TAPS project: Predicting the community costs of closing psychiatric hospitals. Br J Psychiatry 1990 157 : 661 670.
16. Chisholm D, Knapp MR, Astin J, Lelliott P, Audini B. The mental health residential care study: Predicting costs from resident characteristics. Br J Psychiatry 1997 170 : 37 42. (Pubitemid 27404776)
17. Simon GE, Katzelnick DJ. Depression, use of medical services and cost-offset effects. J Psychosom Res 1997 42 : 333 344.
18. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995 36 : 1 10.
19. Penchansky R, Thomas JW. The concept of access: Definition and relationship to consumer satisfaction. Med Care 1981 19 : 127 140.
20. Pauly MV, Pagán JA. Spillovers and vulnerability: The case of community uninsurance. Health Aff 2007 26 : 1304 1314.
21. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Use of health services by previously uninsured medicare beneficiaries. N Engl J Med 2007 357 : 143 153.
22. Mechanic D, Cleary PD, Greenley JR. Distress syndromes, illness behavior, access to care and medical utilization in a defined population. Med Care 1982 20 : 361 372.
23. Drapalski AL, Milford J, Goldberg RW, Brown CH, Dixon LB. Perceived barriers to medical care and mental health care among veterans with serious mental illness. Psychiatr Serv 2008 59 : 921 924.
24. Pescosolido BA, Boyer CA. How do people come to use mental health services? Current knowledge and changing perspectives. In : Horwitz AV, Scheid TL, editors. A handbook for the study of mental health. Cambridge : Cambridge University Press, 1999 392 411.
25. Zuvekas SH, Fleishman JA. Self-rated mental health and racial/ethnic disparities in mental health service use. Med Care 2008 46 : 915 923.
26. Gilmer TP, Ojeda VD, Barrio C, Fuentes D, Garcia P, Lanouette NM, Lee KC. Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency. Psychiat Serv 2009 60 : 175 182.
27. Manning W, Wells KB. The effects of psychological distress and psychological well-being on use of medical services. Med Care 1992 30 : 541 553.
28. Simon G, Ormel J, Von Korff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995 152 : 352 357.
29. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Henk HJ. Effect of primary care treatment of depression on service use by patients with high medical expenditures. Psychiatr Serv 1997 48 : 59 64.
30. Simon G, Von Korff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry 1995 52 : 850 856.
31. Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psychiatry 1996 53 : 899 904.
32. Rush AJ, Fava M, Wisniewski SR et al. Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Control Clin Trials 2004 25 : 119 142. (Pubitemid 38230109)
33. Fava M, Rush AJ, Trivedi MH et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003 26 : 457 494.
34. Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 2006 163 : 28 40.
35. Rush AJ, Trivedi MH, Wisniewski SR et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006 354 : 1231 1242.
36. Trivedi MH, Fava M, Wisniewski SR et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006 354 : 1243 1252.
37. Lavori PW, Rush AJ, Wisniewski SR et al. Strengthening clinical effectiveness trials: Equipoise-stratified randomization. Biol Psychiatry 2001 50 : 792 801.
38. Wisniewski SR, Fava M, Trivedi MH et al. Acceptability of second-step treatments to depressed outpatients: A STAR*D Report. Am J Psychiatry 2007 164 : 753 760.
39. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC : American Psychiatric Association, 1994.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 12 : 52 62.
41. Rush AJ, Bernstein IH, Trivedi MH et al. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression trial report. Biol Psychiatry 2006 59 : 493 501.
42. Rush AJ, Carmody TJ, Ibrahim HM et al. Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv 2006 57 : 829 837.
43. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and SelfReport (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 2004 34 : 73 82.
44. Rush AJ, Trivedi MH, Ibrahim HM et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003 54 : 573 583 erratum p. 585.
45. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001 58 : 787 794.
46. Davis LL, Frazier E, Husain MM et al. Substance use disorder comorbidity in major depressive disorder: A confirmatory analyses of the STAR*D cohort. Am J Addict 2006 15 : 278 285.
47. Ware JE, Kolinsky M, Keller SD. The 12-item ShortForm Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996 34 : 220 223.
48. Kashner TM, Trivedi MH, Wicker A, Fava M, ShoresWilson K, Wisniewski SR, Rush AJ. Release bias in accessing medical records in clinical trials: A STAR*D report. Int J Method Psychiatr Res, In press.
49. Kashner TM, Rush AJ, Crismon ML et al. Cost-outcome in the Texas Medication Algorithm Project: An empirical analysis. Psychiatr Serv 2006 57 : 648 659.
50. Kashner TM, Suppes T, Rush AJ, Altshuler KZ. Measuring use of outpatient care among mentally ill individuals: A comparison of self- reports and provider records. Eval Program Plann 1999 22 : 31 39.
51. Kashner TM, Rush AJ, Altshuler KZ. Measuring costs of guideline-driven mental health care: The Texas Medication Algorithm Project. J Mental Health Policy Econ 1999 2 : 111 121.
52. Rush AJ, Crismon ML, Kashner TM et al. Texas Medication Algorithm Project - Phase 3 (TMAP-3): Rationale and study design. J Clin Psychiatry 2003 64 : 357 369.
53. Kashner TM, Stensland MD, Lind L, Wicker A, Rush AJ, Golden RM, Henley SS. Measuring utilization and cost of care for patients with mood disorders: The utilization and cost inventory. Med Care 2009 47 : 184 190.
54. Kashner TM, Trivedi MH, Wicker A et al. Voice response system to measure health care costs: A STAR*D report. Am J Manag Care 2009 15 : 153 162.
55. American Medical Association. Current procedural terminology. Reston, VA : St. Anthony, 2004.
56. Centers for Medicare and Medicaid Services. Healthcare Common Procedure Coding System (HCPCS). http://www.cms.hhs.gov/medicare/hcpcs (accessed 11/01/2003).
57. St. Anthony's DRG guidebook (2004). Reston, VA : St. Anthony, 2004.
58. (68) 70 F.R. 18465 (April 11, 2005);68(82) F.R. 22773 (4/29/2003), 68(82) F.R. 22966 (4/29/2003), 38 C.F.R. 17.101;66 (89) F.R. 23326 (5/8/2001), and 64 F.R. 22676 (10/1/1999), based on the Balanced Budget Act of 1997, PL 105-33, Sec. 8023(d), 38 USC 1729.
59. Mirandola M, Ammaddeo F, Dunn G, Tansella M. The effect of previous psychiatric history on the cost of care: A comparison of various regression models. Acta Psychiatr Scand 2004 109 : 132 139.
60. Kilian R, Matschinger H, Loeffler W, Roick C, Angermeyer MC. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Mental Health Policy Econ 2002 5 : 21 31.
61. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Ann Rev Public Health 1999 20 : 125 144.
62. Dunn G, Mirandola M, Amaddeo F, Tansella M. Describing, explaining or predicting mental health care costs: A guide to regression models. Br J Psychiatry 2003 183 : 398 404.
63. McCrone P, Knapp M, Fombonne E. The Maudsley long-term follow-up of child and adolescent depression. Predicting costs in adulthood. Eur Child Adolesc Psychiatry 2005 14 : 407 413.
64. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 2004 23 : 525 542.
65. Duan N, Manning WG Jr., Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat 1983 1 : 115 126.
66. Mullahy J. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998 17 : 247 281.
67. Manning WG Jr. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998 17 : 283 295.
68. Alegría M, Chatterji P, Wells K et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv 2008 59 : 1264 1272.
69. Donabedian A. Aspects of medical care administration. Cambridge, MA : Harvard University Press, 1973.